Clinical trial
Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and…
NCT00304499 · Alza Corporation, DE, USA, Industry · Completed
Key facts
| NCT number | NCT00304499 |
|---|---|
| Title | Efficacy and Safety of OROS Oybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence |
| Official title | Efficacy and Safety of OROS® Oxybutynin and TTS Oxybutynin in Middle-Aged and Elderly Women With Urinary Incontinence |
| Lead sponsor | Alza Corporation, DE, USA, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Urinary Incontinence |
| Intervention type | Drug |
| Interventions | Oxybutynin |
| Enrollment | 176 |
| Start date | Dec 1, 1995 |
| Completion | Dec 1, 1996 |
| First posted | Mar 20, 2006 |
| Last update posted | May 19, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: